Gerdi Strydom | Managing Director
Valid Insight

Gerdi Strydom is the Managing Director at Valid Insight, a consultancy that specialises in global market access strategy, payer evidence, and value communication. With over 20 years of leadership experience in the biopharmaceutical industry, consulting, and working as a payer, she offers a well-rounded perspective on access challenges worldwide. Gerdi has extensive expertise in developing effective strategies to ensure the successful launch, reimbursement, and adoption of innovative therapies. She collaborates with companies around the globe to navigate payer expectations, shape evidence strategies, and engage with Health Technology Assessment (HTA) bodies. This work ensures that products demonstrate their value and ultimately reach patients. Her experience encompasses oncology, immunology, vaccines, and other advanced treatments, guiding clients through complex negotiations and access pathways. At Valid Insight, which is part of the Bioscript Group, Gerdi leads a multidisciplinary team that develops strategies aimed at optimal brand positioning, meaningful stakeholder engagement, and increased patient access to transformative therapies worldwide.